Q3 - 2024

[LC]

@cwericb

I'm in a similar boat: Today, Fairfax and Aecon respectively made up 40% and 25% of my investable portfolio (there are some 401k stuff with limited options, and private RE/businesses I exclude from this). Friday was a pretty solid day.

 

Even after Friday's spike, neither Fairfax nor Aecon look particularly expensive:

 

Fairfax trades now at like 1.3x book, for a company with guaranteed earnings for the next few years and management with a real plan to leverage that.

Aecon is trading still in the mid single digit PE-range  given their run-rate adjusted earnings, with industry tailwinds behind them.

 

My goal thru end of year is the remaining call it 35% of my portfolio needs a harder look. JOE, Citi, the MSG complex, FRPH, O&G, etc...this stuff has value but unsure timelines. 

[cwericb]

"Even after Friday's spike, neither Fairfax nor Aecon look particularly expensive: "

 

Fully agree with you LC. I also have a position in ATRL which I have had for a couple of years and it is atill doing pretty well and I also plan on holding onto it as well.

Edited Saturday at 10:04 PM by cwericb

[Haryana]

On 11/2/2024 at 8:10 AM, TB said:

Congrats to @Viking who has been yelling from rooftops with his tome of research (I re-entered in a big way at much lower prices, thanks to his quote - "the big fish that got away"!)  @Haryana @Parsad and all the other bulls. 

I am a nobody here in absolute amount but likely on top in concentration.

My main account is ~85% Fairfax ~10% Fairfax India ~5% cash.

[valuesource]

11 hours ago, Haryana said:

I am a nobody here in absolute amount but likely on top in concentration.

My main account is ~85% Fairfax ~10% Fairfax India ~5% cash.

That probably means you bought it lower and haven't sold on the way up.  Good work!

[Hoodlum]

BMO Capital analyst Tom MacKinnon raised the price target on Fairfax from $1,850 to $2,200.00 Cdn.  Maybe someone can share his report.